♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              530 Comparative Outcome Analysis for Patients with a Neuropathic Fracture Undergoing ORIF Versus Tibiotalocalcaneal (TTC) Fusion

              Author:Spencer Demedal, MS  Kelly Dopke, MD  Irene Laleye  Nathan Smith, MD  Kirsten Mansfield  Samantha Olson  Tonya King, PhD  Jana Davis, MD,FAAOS  Michael Aynardi, MD,FAAOS  

              Event Title:(521-532) VIPER: Foot and Ankle IV Papers  

              Event Type:Paper Presentations  

              Category-Classification:Foot and Ankle  

              Event Day:Thursday, March 13  

              e320 Increased Readmission Rate and Proportion of Smokers, but not Diabetics, in Revision TAA Patients compared to Primary TAA Patients

              Author:Nathan Smith, MD  Kelly Dopke, MD  Akhil Bolisetti  Kelan Queenan, BS  Amar Kassim  Tonya King, PhD  Luigi Andrew Sabal, MD  Michael Aynardi, MD,FAAOS  

              Event Title:e301-e325 Foot and Ankle ePosters  

              Event Type:ePosters  

              Category-Classification:Foot and Ankle  

              Event Day:Monday, March 10